MarketWatchCenter·
Moderna’s stock doubles on promising cancer-vaccine results
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Read at MarketWatch →
Markets · 1 sources covering this
Moderna’s stock doubles on promising cancer-vaccine results
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/c9cce556173d1ee9f144327137a17337bbc3f1b1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna’s stock doubles on promising cancer-vaccine results"></iframe>
